This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.Latest News Cilta-Cel Leads to 100% MRD-Negativity Rate in High-Risk Smoldering Multiple Myeloma By Gina Mauro December ...
MedCity News multiple myelomaBioPharma, Pharma ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More A multiple myeloma cell therapy has encouraging results analysts say could make it best in its class and a gene-editing therapy is showing early promise in ...
At the ESH 7th Translational Research Conference on Multiple Myeloma in 2024, the Multiple Myeloma... Dec 2, 2024 Add bookmark IberDd for transplant-ineligible patients with NDMM: Results from the phase I/II CC-220-MM-001 trial We summarize results from the phase I/II CC-220-MM-001 tria...
Multiple Myeloma Survivor and Advocate Shares 12-Step Program: How Not to Die of Cancer Facing mortality can be a paralyzing experience for some people, but for others, it may ignite a passion to accelerate life. One such person is Kathy Giusti, cofounder of the Multiple Myeloma Research Foun...
More News Isatuximab Combo Improves PFS in Newly Diagnosed Multiple Myeloma Kristi Rosa December 26th 2024 An isatuximab-based quadruplet yields significant long-term benefits regardless of subsequent maintenance in in patients with transplant-eligible NDMM. ...
The Multiple Myeloma Hub newsletter provides healthcare professionals with up-to-date global advances in multiple myeloma relating to their classification, diagnosis, treatment, and management. Each month our team research the latest unmet educational needs and produce evidence-based articles, videos, and...
Multiple Myeloma Research Consortium (MMRC), Emory University Commence Multi-Center Combination Study for the Treatment of Multiple MyelomaEducation
Multiple myeloma (MM) is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein (M protein), destruction of bone, and displacement of other hematopoietic cell lines. [1] First described in 1848, MM is part of...
Whether this is your first race or you are a seasoned competitor, a training plan will help you be prepared when race day arrives. Get started now with a training plan designed by Tom Holland, leading running coach. What You Get A personal training calendar powered by TrainingPeaks. Log ...
The availabilityof numerous new agents for treating multiple myeloma has created some “conundrums” for clinicians, saidSergio Giralt, MD, Deputy Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center and the Melvin Berlin Family Chair in Myeloma Research and Profes...